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Introduction {#sec1}
============

In mammals, sounds are perceived through mechanosensory hair cells located in the sensory epithelium of the cochlea (the organ of Corti). Within the organ of Corti, hair cells and several types of specialized supporting cells are arranged in a regular mosaic pattern that extends along the basal-to-apical axis of the cochlear duct. The organ of Corti contains one row of inner hair cells and three rows of outer hair cells separated by two parallel rows of non-sensory pillar cells (PCs). At birth, all cells of the organ of Corti are closely connected and the inner PCs (IPCs) abut on the adjacent outer PCs (OPCs) through E-cadherin-based homophilic adhesion interactions ([@bib22], [@bib54]) (red curve in [Figure 1](#fig1){ref-type="fig"}A). When mature, i.e., from 2 weeks of age (postnatal day 14, P14) in mice, these rows of PCs form the boundaries of a functionally important triangular fluid-filled space referred to as the tunnel of Corti ([@bib42]) ([Figure 1](#fig1){ref-type="fig"}B). Previous studies have suggested that proper development of the tunnel of Corti is required for hearing ([@bib4], [@bib5], [@bib17]). Indeed, the somatic motility of outer hair cells produces oscillatory fluid flow in the tunnel of Corti, which is critical for cochlear amplification ([@bib24]). The molecules underlying PC fate acquisition are now well characterized and include fibroblast growth factors and their receptors ([@bib5], [@bib9], [@bib19], [@bib33]). In contrast, the mechanisms leading to local IPC/OPC separation remain elusive. However, a critical step should be the progressive loss of the adhesion protein E-cadherin from the lateral membranes of the PCs ([@bib22], [@bib54]) ([Figure 1](#fig1){ref-type="fig"}).Figure 1Schematic Representation of E-Cadherin Localization between Immature and Mature Adjacent IPC and OPC(A) At the immature stage, all the cells of the organ of Corti are closely connected and the IPCs abut on the OPCs through E-cadherin-based homophilic adhesions (in red).(B) When mature, the IPCs and OPCs form the boundaries of a triangular fluid-filled space and only the apical extremities of the PCs are still connected through E-cadherin adhesions (in red).IHC, inner hair cell; IPC, inner pillar cell; OHC, outer hair cell; OPC, outer pillar cell; TC, tunnel of Corti.

An attractive candidate for this process is Eph/ephrin signaling, which has been shown to control several aspects of cochlear development ([@bib7], [@bib6]). The large Eph receptor family has been classified into two subclasses, EphA and EphB receptors, according to their affinity for either glycosylphosphatidylinositol-anchored ephrin-A or transmembrane ephrin-B ligands ([@bib13]). However, some cross-class interactions are possible, as EphA4 can also bind to ephrin-B ligands ([@bib2], [@bib41]). Upon binding, receptor clustering initiates a "forward signaling" but receptor-ligand interaction can also stimulate a "reverse signaling" downstream of the ephrin ligand ([@bib25]). The special case of antiparallel signaling occurs when ephrin and Eph are co-expressed on two apposed cells and result in Eph receptor forward signaling in both directions ([@bib23], [@bib43]). During organogenesis, ephrin and Eph receptor genes control a wide range of critical processes such as cell sorting and positioning, and the formation of segmented structures ([@bib23]). Among a broad variety of pathways, EphB/ephrin-B signaling has been shown to dictate the destruction of E-cadherin-based adhesions in the intestinal epithelium ([@bib49]). Beside EphB receptors, EphA4 also affects the expression of E-cadherin in cancer cells ([@bib8], [@bib29]), suggesting this protein as a good candidate for patterning the tunnel of Corti through local downregulation of adherens junctions.

Here we show that EphA4 and its ligand ephrin-B2 are each expressed on both sides of the IPC/OPC junction. These adjacent PCs fail to separate from each other, and E-cadherin abnormally persists at the PC junction in EphA4 forward-signaling-deficient mice, as well as in the presence of ADAM10 inhibitor. By combining immunolabeling and an *in situ* proximity ligation assay, we found that EphA4 forms a complex with E-cadherin and its sheddase ADAM10, which could be activated by ephrin-B2 across the PC junction to trigger the cleavage of E-cadherin. Altogether, our results highlight a key role for EphA4-ADAM10 interplay in patterning the cochlear sensory epithelium.

Results {#sec2}
=======

EphA4 and Ephrin-B2 Are Co-expressed on Both Sides of the IPC/OPC Junction {#sec2.1}
--------------------------------------------------------------------------

At immature stages, all cells of the organ of Corti are closely connected and the IPCs abut on the OPCs ([Figure 1](#fig1){ref-type="fig"}A). As development progresses, the apical ends of the PCs remain connected, forming the reticular lamina, whereas the lateral membranes become no longer apposed, being separated with fluid spaces ([Figure 1](#fig1){ref-type="fig"}B). This process suggests a subcellular mechanism occurring at about half-height of the PC junction to promote a local IPC/OPC detachment. Among the Eph and ephrin families, EphA4 and its ligand ephrin-B2 are frequently involved in cell repulsion and tissue segmentation processes ([@bib31], [@bib55]), including in the developing cochlea ([@bib6]). Therefore, we examined their expression patterns during the postnatal development of the tunnel of Corti. By using an *EphA4*^*+/EGFP*^ reporter mouse model ([@bib14]) combined with ephrin-B2 immunolabeling, we found that EphA4^EGFP^ and ephrin-B2 are co-expressed on both sides of the IPC/OPC junction from postnatal day 4 (P4) ([Figures 2](#fig2){ref-type="fig"}B and 2C), i.e., when the early opening of the tunnel of Corti is initiated ([@bib18]). Importantly, these expression patterns are spatially restricted to the half-height region of the PCs. At postnatal stages, neither EphA4^EGFP^ nor ephrin-B2 is expressed at the apical extremities of the PCs, which remain connected in the mature configuration of the tunnel of Corti ([Figures 2](#fig2){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}). The presence of EphA4 and ephrin-B2 in the PCs from P4 was further confirmed using *in situ* hybridization ([Figure 2](#fig2){ref-type="fig"}D). The corresponding negative controls were obtained using sense probes ([Figure S2](#mmc1){ref-type="supplementary-material"}). These overlapping expression patterns across the IPC/OPC boundary are consistent with findings suggesting that two Eph/ephrin antiparallel forward signals are sufficient to regulate cell-cell detachment. In this case, each pathway involves ephrin ligands on one side and Eph receptors on the other side ([@bib43]).Figure 2EphA4 and Ephrin-B2 Are Co-expressed on Both Sides of the IPC/OPC Junction(A) Schematic representation of a P4 mouse organ of Corti showing the position at which level single confocal images were acquired (here at half-height of PCs, blue segments).(B) F-actin staining and ephrin-B2 immunolabeling of P4 *EphA4*^*+/EGFP*^ whole-mount cochlea showing that EphA4^EGFP^ and ephrin-B2 are co-expressed on both sides of the IPC/OPC junction (yellow arrowheads).(C) Orthogonal projection of P4 *EphA4*^*+/EGFP*^ whole-mount PCs showing that EphA4^EGFP^ and ephrin-B2 are reciprocally co-expressed at about half-height of the PC junction (yellow arrowheads). In contrast, neither EphA4^EGFP^ nor ephrin-B2 is expressed at the apical extremity of the PCs, i.e., where the PCs remain closely connected (red arrowhead).(D) *In situ* hybridization on transversal section of P4 cochlea showing that *EphA4* and *ephrin-B2* are both expressed in the PCs.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}. Scale bars, 2 μm in (B) and (C) and 5 μm in (D). IHC, inner hair cell; IPC, inner pillar cell; OHC, outer hair cell; OPC, outer pillar cell; PC, pillar cell.

IPCs and OPCs Fail to Separate from Each Other in EphA4^EGFP/EGFP^ Mice {#sec2.2}
-----------------------------------------------------------------------

Eph forward signaling rather than ephrin reverse signaling has been shown to dictate the destruction of E-cadherin-based adhesions ([@bib49]) and to promote cell-cell separation ([@bib43]). To test whether EphA4 forward signaling promotes IPC/OPC detachment, we compared the proportion of IPCs that are fully detached from the adjacent OPCs in whole-mount cochleae from P14 wild-type (WT) and knockin mice encoding an EphA4 forward-signaling-deficient isoform ([@bib14]). We found that the percentage of IPCs entirely detached from the adjacent OPCs at half-height of the organ of Corti is significantly decreased in the absence of the EphA4 cytoplasmic domain ([Figure 3](#fig3){ref-type="fig"}B). As a consequence, the classic triangular shape of the tunnel of Corti observed in WT mice failed to correctly develop in *EphA4*^*EGFP/EGFP*^ animals ([Figure 3](#fig3){ref-type="fig"}B). Such defects were found in 75% of the knockin mice (n = 9 out of 12) and in none of the WT mice (n = 8). This level of penetrance in *EphA4*^*EGFP/EGFP*^ mice is similar to previously published data ([@bib10], [@bib40]). In addition, we found that E-cadherin abnormally persists at the IPC/OPC junctions in P14 *EphA4*^*EGFP/EGFP*^ mice ([Figure 3](#fig3){ref-type="fig"}C), suggesting that EphA4 forward signaling downregulates E-cadherin to promote PC detachment. Of note, no earlier defects regarding the PCs were observed in P2 *EphA4*^*EGFP/EGFP*^ mice ([Figure S3](#mmc1){ref-type="supplementary-material"}). The role of EphA4 in the local disruption of adherens junctions was further confirmed in organotypic culture using KYL peptide, a specific inhibitor of EphA4 ([@bib27]) ([Figure 3](#fig3){ref-type="fig"}D).Figure 3IPCs and OPCs Fail to Separate from Each Other in the Absence of EphA4 Signaling(A) Schematic representation of a mature (P14) organ of Corti showing the position at which level single confocal images were acquired (here at half-height of PCs, blue segments).(B) F-actin and DAPI nuclear staining of P14 WT and *EphA4*^*EGFP/EGFP*^ whole-mount cochleae. Upper panels: orthogonal reconstruction of confocal images showing the presence (double-headed arrow) or the absence (asterisk) of a triangular space between the IPC and OPC in WT or *EphA4*^*EGFP/EGFP*^ cochlea, respectively. Lower panels: confocal images showing that, in WT mice, all the IPCs are detached from the OPCs, allowing the formation of the tunnel of Corti (double-headed arrow). In *EphA4*^*EGFP**/EGFP*^ mice, a few IPCs are fully detached from the adjacent OPCs (inset, orange arrowheads) and a majority of PCs remain attached to each other (inset, yellow arrowheads). Right panel: the percentage of IPCs detached from OPCs is significantly decreased in *EphA4*^*EGFP/EGFP*^ when compared with WT mice. n = 200 IPCs from four animals of both genotypes.(C) F-actin staining and E-cadherin immunolabeling of P14 *EphA4*^*EGFP/EGFP*^ whole-mount cochlea showing that E-cadherin abnormally persists at the IPC/OPC junction (yellow arrowheads), whereas it is absent from separated membranes (orange arrowheads).(D) F-actin staining and E-cadherin immunolabeling of organotypic culture treated with KYL peptide showing that E-cadherin persists at the IPC/OPC junction (yellow arrowheads).Data are presented as mean ± SEM. \*\*\*p \< 0.001. See also [Figure S3](#mmc1){ref-type="supplementary-material"}. Scale bars, 5 μm in (B) and 2 μm in (C) and (D). IHC, inner hair cell; IPC, inner pillar cell; OHC, outer hair cell; OPC, outer pillar cell; TC, tunnel of Corti.

EphA4 Forms a Complex with E-Cadherin and ADAM10 at the IPC/OPC Junction {#sec2.3}
------------------------------------------------------------------------

To decipher the molecular mechanisms through which EphA4 downregulates the adherens junctions in the cochlea, we examined whether EphA4^EGFP^ associates with E-cadherin and ADAM10. This disintegrin and metalloproteinase promotes the shedding of E-cadherin ([@bib30]) and constitutively associates with Eph receptors via specific regions in their extracellular domains ([@bib20]). From P6, some fluid-filled spaces begin to intersperse the two rows of adjacent PCs ([@bib18]). At this stage, we found that, at half-height of the PCs, E-cadherin (yellow arrowheads in [Figure 4](#fig4){ref-type="fig"}B) and ADAM10 (yellow arrowheads in [Figure 4](#fig4){ref-type="fig"}C) co-localized with EphA4^EGFP^ at the IPC/OPC junction in *EphA4*^*+/EGFP*^ mice, and with ADAM10 in WT mice (yellow arrowheads in [Figures 4](#fig4){ref-type="fig"}D and 4E). Concomitantly, we observed that EphA4^EGFP^ (orange arrowheads in [Figure 4](#fig4){ref-type="fig"}C), E-cadherin (orange arrowheads in [Figure 4](#fig4){ref-type="fig"}D), and ADAM10 (orange arrowheads in [Figures 4](#fig4){ref-type="fig"}C and 4D) disappeared as soon as the membranes were detached from each other, suggesting that these three proteins are closely involved in cell-cell separation. In contrast, the expression of E-cadherin was maintained at apical extremities of the PCs, as expected ([@bib22], [@bib54]) (red arrowhead in [Figures 4](#fig4){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}). Similarly to EphA4^EGFP^, ADAM10 was not found at the apical ends of PCs, i.e., where the IPCs and OPCs remain attached to each other (red arrowhead in [Figures 4](#fig4){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}). To test whether EphA4 interacts *in vivo* with E-cadherin and ADAM10 at the IPC/OPC junction, we performed two types of *in situ* proximity ligation assays ([@bib48]). In *EphA4*^*+/EGFP*^ animals, positive signals (detected as fluorescence red spots) revealed that EphA4^EGFP^ closely associated with E-cadherin and ADAM10, and that E-cadherin associated with ADAM10 at half-height of the PCs ([Figure 5](#fig5){ref-type="fig"}B). Of note, the loss of cytoplasmic domain in EphA4^EGFP^ did not abolish the interaction with ADAM10, which occurs constitutively through mutual extracellular domains ([@bib20]). As expected, no positive signals were observed at apical extremities of the IPC/OPC junction, i.e., where PCs remain closely connected ([Figure S5](#mmc1){ref-type="supplementary-material"}). Negative controls obtained by omitting one of the primary antibodies further confirmed that our proximity ligation assay signals were indicative of protein interactions ([Figure 5](#fig5){ref-type="fig"}C). In WT mice, positive signals revealed that EphA4 interacts with E-cadherin and ADAM10, and negative controls were obtained by pre-incubating the anti-EphA4 antibody with a blocking peptide ([Figure S6](#mmc1){ref-type="supplementary-material"}). These results suggest that EphA4, E-cadherin, and ADAM10 form a complex that could be recognized and activated by ephrin-B2 across the PC junction to promote the cleavage of E-cadherin.Figure 4EphA4 Co-localizes with E-Cadherin and ADAM10 at the IPC/OPC Junction(A) Schematic representation of a P6 mouse organ of Corti showing the position at which level single confocal images were acquired (here at half-height of PCs, blue segments).(B) F-actin staining and E-cadherin immunolabeling of P6 *EphA4*^*+/EGFP*^ whole-mount cochlea showing that EphA4^EGFP^ and E-cadherin co-localize on both sides of the IPC/OPC junction (yellow arrowheads).(C) F-actin staining and ADAM10 immunolabeling of P6 *EphA4*^*+/EGFP*^ whole-mount cochlea showing that EphA4^EGFP^ and ADAM10 co-localize on both sides of the IPC/OPC junction (yellow arrowheads) and disappear as soon as the membranes are detached from each other (orange arrowheads).(D) F-actin staining, E-cadherin, and ADAM10 immunolabeling of P6 WT whole-mount cochlea showing that E-cadherin and ADAM10 co-localize on both sides of the IPC/OPC junction (yellow arrowheads) and disappear as soon as the membranes are detached from each other (orange arrowheads).(E) Orthogonal projection of P6 WT whole-mount PCs showing that E-cadherin and ADAM10 are reciprocally co-expressed at about half-height of the PC junction (yellow arrowheads). In contrast, E-cadherin but not ADAM10 is present at the apical extremity of the PC junction, i.e., where the PCs remain closely connected (red arrowhead).See also [Figure S4](#mmc1){ref-type="supplementary-material"}. Scale bars, 2 μm in (B--D) and (E). IHC, inner hair cell; IPC, inner pillar cell; OHC, outer hair cell; OPC, outer pillar cell.Figure 5EphA4 Forms a Complex with E-Cadherin and ADAM10 at the IPC/OPC Junction(A) Schematic representation of a P6 mouse organ of Corti showing the position at which level single confocal images were acquired (here at half-height of PCs, blue segments).(B) *In situ* proximity ligation assay showing that EphA4^EGFP^ interacts with E-cadherin and ADAM10, as well as E-cadherin with ADAM10 at half-height of the IPC/OPC junction. Protein-protein interactions are detected as fluorescent red spots.(C) Proximity ligation assay negative controls were performed using a single primary antibody (ab): anti-GFP, mouse, or rabbit anti-E-cadherin and anti-ADAM10.See also [Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}. Scale bars, 2 μm in (B) and (C). IHC, inner hair cell; IPC, inner pillar cell; OHC, outer hair cell; OPC, outer pillar cell; PLA, proximity ligation assay.

ADAM10 Inhibition Prevents the Separation of PCs {#sec2.4}
------------------------------------------------

To test whether ADAM10 cooperates with EphA4 to promote PC separation, we performed an organotypic *in vitro* assay aimed at blocking the endogenous activity of ADAM10 using GI254023X. We found that the percentage of IPCs entirely detached from the adjacent OPCs at half-height of the organ of Corti is significantly decreased in the presence of ADAM10 inhibitor ([Figure 6](#fig6){ref-type="fig"}B). In addition, we found that E-cadherin persists at the IPC/OPC junctions in treated organotypic culture ([Figure 6](#fig6){ref-type="fig"}C), suggesting that ADAM10 downregulates E-cadherin to promote PC detachment. Moreover, the EphA4/ephrin-B2 complex persists at the IPC/OPC junction in the presence of ADAM10 inhibitor, meaning that ADAM10 protease activity is also required for the cleavage of the Eph/ephrin complex and further cell-cell detachment, as previously described ([@bib20], [@bib21]) ([Figure 6](#fig6){ref-type="fig"}D).Figure 6IPCs and OPCs Fail to Separate from Each Other in the Presence of ADAM10 Inhibitor(A) Schematic representation of a P8 organ of Corti showing the position at which level single confocal images were acquired (here at half-height of PCs, blue segments).(B) F-actin staining of organotypic culture treated with DMSO or with ADAM10 inhibitor (GI254023X). Organs of Corti from P2 mice were cultured for 6 days *in vitro*. Left panels: confocal images showing that, in control condition (DMSO), about half of the IPCs are separated from the OPCs (red asterisks). In the presence of GI254023X, few IPCs are fully detached from adjacent OPCs (red asterisks) and a large majority of PCs remain attached to each other. Right panel: the percentage of IPCs detached from OPCs is significantly decreased in the presence of GI254023X when compared with the control condition. This effect is concentration dependent. n = 300 IPCs from three independent experiments.(C) Upper panels: F-actin staining and E-cadherin immunolabeling showing that E-cadherin abnormally persists at the IPC/OPC junction (yellow arrowheads) in culture treated with GI254023X. Lower panels: F-actin staining and EphA4 and ephrin-B2 immunolabeling showing that the EphA4/ephrin-B2 complex persists at the IPC/OPC junction (yellow arrowheads) in culture treated with GI254023X.Data are presented as mean ± SEM. \*\*p \< 0.01, \*\*\*p \< 0.001. Scale bars, 5 μm in (B) and (C). IHC, inner hair cell; IPC, inner pillar cell; OHC, outer hair cell; OPC, outer pillar cell.

Disruption of Adherens Junctions Rescues the EphA4 Loss of Function {#sec2.5}
-------------------------------------------------------------------

Finally, we examined whether PC separation could be restored despite the loss of EphA4 activity. To this end, we performed a "two-step" organotypic *in vitro* assay. First, organs of Corti were pre-treated with KYL peptide to block the process of PC separation. Cultures were then incubated with an E-cadherin-neutralizing antibody, DECMA-1 mAb, aimed to promote the disruption of adherens junctions ([@bib53]). We found that E-cadherin downregulation efficiently rescues the EphA4 loss of function and restores the PC separation ([Figure 7](#fig7){ref-type="fig"}).Figure 7Disruption of Adherens Junctions Rescues the EphA4 Loss of Function(A) Schematic representation of a P8 organ of Corti showing the position at which level single confocal images were acquired (here at half-height of PCs, blue segments).(B) F-actin staining of organotypic culture treated with DMSO, with KYL peptide, or with KYL peptide and DECMA-1 mAb. Organs of Corti from P2 mice were cultured for 6 days *in vitro*. In control condition (DMSO), about half of the IPCs are separated from the OPCs (red asterisks). In the presence of KYL peptide, a few IPCs are fully separated from the adjacent OPCs (red asterisks) and a large majority of PCs remain attached to each other. The addition of DECMA-1 mAb to KYL peptide significantly rescues the percentage of IPCs detached from the OPCs. n = 300 IPCs from three independent experiments.Data are presented as mean ± SEM. \*\*p \< 0.01. Scale bar, 5 μm in (B). IHC, inner hair cell; IPC, inner pillar cell; OHC, outer hair cell; OPC, outer pillar cell.

Discussion {#sec3}
==========

Here we show that two antiparallel EphA4 forward signals promote the destruction of E-cadherin-based adhesions between adjacent cochlear PCs. Our results support that EphA4, E-cadherin, and its sheddase ADAM10 form a complex that could be activated by ephrin-B2 across the PC junction to promote the cleavage of E-cadherin by ADAM10. Among EphA4-binding partners, ephrin-B2 and ephrin-B3 are especially involved in cell-cell separation ([@bib44]). As ephrin-B3 is apparently not expressed in cochlear PCs ([@bib57]), ephrin-B2 is the most likely partner of EphA4 to promote PC detachment. Previous data have shown that, upon binding, EphA3 clustering and auto-phosphorylation result in release of the intracellular tyrosine kinase domain away from the cell membrane into a conformation that facilitates the productive alignment with ADAM10 and the correct orientation of its protease domain ([@bib21]). In agreement, our data suggest a model in which, upon binding in both directions across the PC junction, the *trans*-activation of EphA4 results in a productive association with ADAM10 through cytoplasmic domains. The *cis*-activation of ADAM10 by EphA4 leads to cleavage of E-cadherin and cell-cell detachment ([Figure 8](#fig8){ref-type="fig"}A). In contrast, in mice lacking the cytoplasmic domain of EphA4, ADAM10 cannot be *cis*-activated by EphA4 and fails to orientate its protease domain for the cleavage of E-cadherin. As a consequence, E-cadherin persists at the cell junction and the adjacent PCs fail to separate from each other ([Figure 8](#fig8){ref-type="fig"}B). Together, our results suggest a key role for antiparallel Eph receptor activation. Whereas a single Eph receptor forward signaling induces cell sorting through cleavage of E-cadherin ([@bib49]), two antiparallel Eph receptor forward signals promote cell-cell separation.Figure 8A Model for How Antiparallel EphA4 Forward Signaling Promotes the Disruption of Adherens Junctions(A) In WT mice, the *trans*-activation of EphA4 on both sides of the IPC/OPC junction results in a productive alignment with ADAM10 through cytoplasmic domains. This association mediates the correct orientation of the protease domain for cleavage of E-cadherin and further cell-cell detachment.(B) In mice in which the EphA4 cytoplasmic domain has been replaced by EGFP, ADAM10 cannot be *cis*-activated by EphA4 and correctly orientate its protease domain for cleavage of E-cadherin. As a consequence, IPCs and OPCs fail to separate from each other. IPC, inner pillar cell; OPC, outer pillar cell.

This mechanism of adherens junction downregulation by EphA4 might be extended to a broad range of physiological or pathological processes. In cancer with poor prognosis, EphA4 and E-cadherin appear to be regulated in opposite ways. On the one hand, the loss of E-cadherin expression is associated with tumor development, metastatic dissemination, and poor patient prognosis ([@bib36], [@bib45], [@bib52]). On the other hand, EphA4 is overexpressed in a wide range of cancers (including glioblastoma, pancreatic, colorectal, gastric, prostate, and breast cancers) and is often associated with poor patient prognosis and shorter survival ([@bib1], [@bib3], [@bib12], [@bib15], [@bib16], [@bib28], [@bib32], [@bib37], [@bib39]). Moreover, it has been shown that high EphA4 expression negatively correlates with metastasis-free survival ([@bib3], [@bib28], [@bib32], [@bib39]). In this context, EphA4 promotes the motility and invasion of pancreatic cancer cells in part through the downregulation of E-cadherin ([@bib29]). Loss of E-cadherin is a primary event in the initiation of epithelial-mesenchymal transition (EMT) ([@bib38], [@bib51]). Recent studies suggest that EMT particularly contributes to recurrent metastasis formation after chemotherapy ([@bib11], [@bib56]). Interestingly, overexpression of EphA4 predicts a lesser degree of tumor regression after neoadjuvant chemoradiotherapy in rectal cancer ([@bib28]). In addition, EphA4 signaling regulates the aggressive phenotype of irradiated colorectal cancer cells. Irradiation increases the activation of EphA4 in survivor colorectal cancer cells and promotes the internalization of an EphA4/E-cadherin complex, inducing cell-cell adhesion disruption ([@bib8]). Furthermore, EphA4 knockdown in the progeny of irradiated cells reduces the migratory and invasive potentials ([@bib8]). These findings have triggered numerous efforts that currently seek to develop pharmacological inhibitors of EphA4 for clinical use ([@bib27], [@bib26], [@bib35], [@bib46], [@bib50]). At least as a regulator of adherens junctions, EphA4 now emerges as an attractive therapeutic target to prevent cancer cell dissemination and metastasis, including strategies aimed at overcoming chemo- and/or radioresistance.

Limitations of the Study {#sec3.1}
------------------------

Our results suggest that EphA4 forms a complex with E-cadherin and its sheddase ADAM10, which could be activated by ephrin-B2 across the PC junction to trigger the cleavage of E-cadherin. The first limitation concerns the real function of ephrin-B2 in this process, which was not addressed in this work. The second limitation concerns the presumed cleavage of E-cadherin by ADAM10, which was not directly proven in this study.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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